KIRSCH ARTHUR S
SEC Form 4 insider trading activity
KIRSCH ARTHUR S has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including EVMN, LQDA, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 9, 2026.
On the most recent filing, KIRSCH ARTHUR S is listed as Director at Evommune, Inc. Inside the rolling window, KIRSCH ARTHUR S reported 1 open-market purchase totaling $133K in EVMN and 3 open-market sales totaling $1.7M in LQDA. The largest disclosed transaction in the window is a sale of 15,000 LQDA shares on Jun 1, 2026, worth $903K.
Companies traded
Other insiders at EVMN
Insider Buying
$133K
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KIRSCH ARTHUR S made?
KIRSCH ARTHUR S has filed 3 SEC Form 4 filings (5 transaction rows) across 2 companies, including EVMN, LQDA since 2026.
Which companies does KIRSCH ARTHUR S trade?
KIRSCH ARTHUR S has filed SEC Form 4 disclosures for 2 companies, including EVMN, LQDA.
When was KIRSCH ARTHUR S's most recent SEC Form 4 filing?
KIRSCH ARTHUR S's most recent SEC Form 4 filing on Tracefour is dated Jul 9, 2026.
What is KIRSCH ARTHUR S's total buy and sell value in the current window?
Inside the rolling retention window, KIRSCH ARTHUR S bought $133K and sold $1.7M based on SEC Form 4 filings.
What was KIRSCH ARTHUR S's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 LQDA shares on 2026-06-01, worth $903K, per SEC Form 4 filings.